戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ng to inflation of BED for SIRT and possible undertreatment.
2 ment and treatment-related sequelae but also undertreatment.
3 all but the BRVO-anti-VEGF group, suggesting undertreatment.
4 oor baseline VA may be particularly prone to undertreatment.
5 e-recommended statin dosing, and reasons for undertreatment.
6                     Medication use suggested undertreatment.
7 ier disease reactivation, perhaps because of undertreatment.
8 idual treatment regimens and avoid potential undertreatment.
9 icates substantial overtreatment and limited undertreatment.
10 vent asthma, this study suggests significant undertreatment.
11 he result of disease progression or possible undertreatment.
12  wheeze will likely be an important cause of undertreatment.
13  predictive of adherence, overtreatment, and undertreatment.
14  dosimetry is required to avoid toxicity and undertreatment.
15 classification, distorted communication, and undertreatment.
16 ich are leading to potentially inappropriate undertreatment.
17 fter breast-conserving surgery (BCS) suggest undertreatment.
18 nteractions can lead to either overdosing or undertreatment.
19 cific outcomes may lead to overtreatment and undertreatment.
20 , which may contribute to underdiagnosis and undertreatment.
21   Disparities in screening may contribute to undertreatment.
22 have been the efforts in the past to redress undertreatment and how successful have they been?
23                                    The terms undertreatment and overtreatment are often used to descr
24                                              Undertreatment and overtreatment of older adults with ca
25  simplified score by clinicians could reduce undertreatment and overtreatment of older children and a
26                               Definitions of undertreatment and overtreatment were extracted, and cat
27 ppropriate testing and avoids the pitfall of undertreatment and overtreatment.
28 tic criteria and how to balance the risks of undertreatment and overtreatment.
29                            Awareness of this undertreatment and these disparities highlight the need
30  are perpetuated by implicit bias leading to undertreatment and underrepresentation in clinical trial
31 risk of presentation with metastatic cancer, undertreatment, and death resulting from their cancer.
32 en is commonly plagued by delayed diagnoses, undertreatment, and knowledge gaps, particularly in wome
33 over time in order to avoid overtreatment or undertreatment, and the use of supportive care to preven
34                                Nontreatment, undertreatment, and treatment trends determined by the u
35  patients and the factors that contribute to undertreatment are not known.
36 ispanic patients had higher adjusted odds of undertreatment (Black patients: OR, 1.42; 95% CI, 1.29-1
37 n level is at goal to avoid overtreatment or undertreatment, both of which are associated with cardio
38 s the result of various issues that include: undertreatment by clinicians with insufficient knowledge
39 imary open-angle glaucoma (POAG) can lead to undertreatment, disease progression, and irreversible vi
40              Missed or delayed diagnosis and undertreatment do not fully explain this burden of disea
41        Such a state of confusion may lead to undertreatment if combination therapy is indeed superior
42 ypic or due to phenocopying, are at risk for undertreatment if not recognized.
43    Among patients with locoregional disease, undertreatment in females may reflect treatment bias and
44  at 100 to 115 mg/dl may lead to substantial undertreatment in high-risk individuals.
45 t counseling, to assess patterns of over- or undertreatment in older adults with cancer at the system
46  depression may result in underreporting and undertreatment in this population and, thus, a need for
47 rventions are needed for patients at risk of undertreatment, including patients with SI, African Amer
48 -income countries and is likely to result in undertreatment, increased avoidable disability and morta
49 ntly less marked in elderly patients in whom undertreatment is a concern.
50                                     However, undertreatment is still common, and improving patient an
51  guidelines from reliable leading societies, undertreatment is still frequent.
52  The cost to individuals and society of this undertreatment is substantial.
53 macular degeneration (nAMD); however, due to undertreatment, many patients lose vision over time.
54                                              Undertreatment most commonly implied less than recommend
55                     Articles using the terms undertreatment (n = 236), overtreatment (n = 71), or bot
56          Lack of adherence (nonadherence) or undertreatment (nonpersistence) with respect to evidence
57 ticularly given the risk of vision loss with undertreatment observed in the real world.
58 x was associated with lower adjusted odds of undertreatment (odds ratio [OR], 0.82; 95% CI, 0.77-0.88
59 esterol targets of 2.6 mmol/l, may result in undertreatment of a large number of patients.
60                                              Undertreatment of acute pain is suboptimal medical treat
61 g and avoid overtreatment of indolent PC and undertreatment of aggressive disease are urgently needed
62                However, the data indicate an undertreatment of AIT, which may be temporary, but could
63 ectronic health records, which could lead to undertreatment of alcohol use disorder.
64 d from 2007 to 2013, there was a decrease in undertreatment of approximately 25% (from 43.4 to 31.8%)
65 ving anticancer therapy, which could lead to undertreatment of Black patients with cancer and adverse
66 place in pediatric pain management since the undertreatment of children's pain was first reported.
67 entable if the problem of underdiagnosis and undertreatment of depression can be overcome by psychoed
68  consensus conference on the reasons for the undertreatment of depression was organized by the Nation
69  depression used antidepressants, suggesting undertreatment of depression.
70  in screening rates among groups at risk for undertreatment of depression.
71  language barriers are at increased risk for undertreatment of depression.
72 tic changes in glaucoma, in order to prevent undertreatment of disease and overtreatment of suspects.
73        We argue that the findings reflect an undertreatment of female patients' pain.
74  the overtreatment of frail patients and the undertreatment of fit patients.
75 r, these data raise concerns for a potential undertreatment of HF currently that may impact prognosis
76 t both overtreatment of low-risk disease and undertreatment of high-risk disease.
77 tion and medication change suggests possible undertreatment of higher risk patients.
78 ations may result in the underestimation and undertreatment of LDL-C in those at increased risk.
79       This analysis from the LUNAR (Limiting UNdertreatment of lipids in ACS with Rosuvastatin) study
80 y-related bleeding undoubtedly contribute to undertreatment of many patients who would benefit from a
81 s treatment options and help avoid over- and undertreatment of noninvasive breast cancer.
82                                              Undertreatment of older adults with atrial fibrillation
83 ed by 2 reports; both documented significant undertreatment of PAD as a cardiovascular disease risk f
84                                The extent of undertreatment of pain in these patients and the factors
85 and Hispanic cancer patients are at risk for undertreatment of pain.
86 d safe treatment of patients with RA without undertreatment of patients who might benefit from JAK in
87 dividuals and avoidance of overtreatment and undertreatment of patients with conventional chemotherap
88 plication management could contribute to the undertreatment of patients with high-complexity coronary
89                             Nontreatment and undertreatment of patients with psoriasis and psoriatic
90 f the mortality difference was caused by the undertreatment of patients without chest pain, particula
91 y in grading can result in overtreatment and undertreatment of prostate cancer.
92 nce could at least partly be due to relative undertreatment of Swedish patients.
93 pression as well as the underrecognition and undertreatment of the problem.
94     However, in practice, underdiagnosis and undertreatment of these disorders are common, in large p
95 e in BP measurement may lead to unrecognized undertreatment of women and could partly explain why wom
96                    Of particular concern was undertreatment of women compared with men, but much has
97 vasive SBC may help reduce overtreatment and undertreatment of women from minority groups.
98 titles and abstracts that included the terms undertreatment or overtreatment with regard to older adu
99    Receipt of non-guideline-based treatment (undertreatment or overtreatment) for kidney cancer, as d
100 ire careful and regular adjustments to avoid undertreatment or overtreatment.
101 of more than 5 letters, indicating either an undertreatment or that factors other than VA loss were c
102 evealed few instances of rapid response team undertreatment or underuse that may have affected the mo
103 ically significantly higher adjusted odds of undertreatment (OR, 2.63; 95% CI, 2.29-3.01; P < .001) a
104 avoid potentially inappropriate medications, undertreatment, or errors of omissions in older people.
105 for persistent atrial fibrillation (PersAF), undertreatment persists, especially in ECA nonresponders
106  significantly more likely to receive unsafe undertreatment, rather than the guideline-recommended tr
107 and mortality risk, whereas overtreatment or undertreatment (relative to the individual need) may fur
108                 Significant overtreatment or undertreatment (relative to the optimal dose) further in
109 AVR performance grew and was more prompt but undertreatment remained prominent (>40%).
110 rformance grew notably, but while declining, undertreatment remained substantial and disease lethalit
111                                      Data on undertreatment, treatment use, and treatment satisfactio
112 in pain treatment adequacy, with the odds of undertreatment twice as high for minority patients.
113                                              Undertreatment was particularly prominent among minority
114 trend and identify potential determinants of undertreatment, we compared articles published before an
115  with cancer are at risk of overtreatment or undertreatment when decision-making is based solely on c
116 sk of delay in seeking medical attention and undertreatment, which can lead to avoidable deaths.
117 s with T1 bladder cancer are at risk of both undertreatment with persistent use of BCG despite recurr
118 nition of angina by physicians may result in undertreatment with revascularization or medications tha
119  unclear, although some studies suggest that undertreatment with warfarin may be a cause.

 
Page Top